Who's included? The role of the Clinical Research Nurse in enabling research participation for under-represented and under-served groups.
Australia
community-based participatory research
cultural diversity
health equity
health services accessibility
nurses’ role
Journal
Journal of research in nursing : JRN
ISSN: 1744-988X
Titre abrégé: J Res Nurs
Pays: England
ID NLM: 101234311
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
entrez:
8
4
2022
pubmed:
9
4
2022
medline:
9
4
2022
Statut:
ppublish
Résumé
There is a global call for more inclusive clinical research that is representative of all populations, particularly those historically under-represented or under-served. A lack of broad representation results in disproportionate health outcomes and limits the applicability and translation of research findings. Identify and describe barriers to participation across the research lifecycle and consider the role of the Clinical Research Nurse (CRN) in promoting inclusivity, including for Aboriginal and Torres Strait Islander Peoples within Australia. Review of recent literature and best practice identified barriers to research participation across the research process; at system, participant and practitioner levels. This discussion paper explores the role of the CRN; acting as enablers, facilitators and navigators, to mitigate participation barriers. With their comprehensive understanding of the research process, clinical care pathways, reflective practices and participant-centred approaches, CRNs are uniquely positioned to advocate for greater equity in access to clinical research and to motivate stakeholders across the research enterprise to embed inclusive approaches in the design, conduct and dissemination of research. An in-depth understanding of the research process, self, and cultural norms of the populations they serve is essential for CRNs to effectively advocate for equity in access to research.
Sections du résumé
Background
UNASSIGNED
There is a global call for more inclusive clinical research that is representative of all populations, particularly those historically under-represented or under-served. A lack of broad representation results in disproportionate health outcomes and limits the applicability and translation of research findings.
Aim
UNASSIGNED
Identify and describe barriers to participation across the research lifecycle and consider the role of the Clinical Research Nurse (CRN) in promoting inclusivity, including for Aboriginal and Torres Strait Islander Peoples within Australia.
Discussion
UNASSIGNED
Review of recent literature and best practice identified barriers to research participation across the research process; at system, participant and practitioner levels. This discussion paper explores the role of the CRN; acting as enablers, facilitators and navigators, to mitigate participation barriers.
Conclusion
UNASSIGNED
With their comprehensive understanding of the research process, clinical care pathways, reflective practices and participant-centred approaches, CRNs are uniquely positioned to advocate for greater equity in access to clinical research and to motivate stakeholders across the research enterprise to embed inclusive approaches in the design, conduct and dissemination of research.
Implications for Practice
UNASSIGNED
An in-depth understanding of the research process, self, and cultural norms of the populations they serve is essential for CRNs to effectively advocate for equity in access to research.
Identifiants
pubmed: 35392191
doi: 10.1177/17449871221077076
pii: 10.1177_17449871221077076
pmc: PMC8980581
doi:
Types de publication
Journal Article
Langues
eng
Pagination
143-154Informations de copyright
© The Author(s) 2022.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Références
J Clin Nurs. 2021 Mar;30(5-6):e13-e15
pubmed: 32956523
J Clin Oncol. 2017 Nov 20;35(33):3737-3744
pubmed: 28968170
Am J Prev Med. 2016 Jan;50(1):111-117
pubmed: 26470805
N S W Public Health Bull. 2003;14 Suppl 4:1-148
pubmed: 14872217
Nurs Times. 2015 May 6-12;111(19):16-7
pubmed: 26182599
Med J Aust. 2015 Jul 6;203(1):24-7
pubmed: 26126563
Contemp Clin Trials. 2014 Nov;39(2):169-82
pubmed: 25131812
Br J Gen Pract. 2013 Jul;63(612):342-3
pubmed: 23834862
J Health Commun. 2017 Nov;22(11):923-931
pubmed: 29125435
BMC Public Health. 2014 Jun 10;14:579
pubmed: 24912949
Cancer. 2020 Jan 1;126(9):1958-1968
pubmed: 32147815
Acta Paediatr. 2012 Aug;101(8):805-7
pubmed: 22519914
J Transcult Nurs. 2014 Oct;25(4):383-7
pubmed: 24595167
J Health Dispar Res Pract. 2014;7(4):1-13
pubmed: 26295011
Trials. 2016 May 26;17(1):263
pubmed: 27229153
Am J Public Health. 2010 Apr 1;100 Suppl 1:S105-12
pubmed: 20147682
J Prof Nurs. 1999 Mar-Apr;15(2):106-15
pubmed: 10194895
Int Nurs Rev. 2006 Mar;53(1):34-40
pubmed: 16430758
PLoS Med. 2009 Oct;6(10):e1000148
pubmed: 19823568
Med J Aust. 2019 Oct;211(8):345-346.e1
pubmed: 31559640
JAMA Intern Med. 2014 Nov;174(11):1868-70
pubmed: 25264856
Curr Probl Cardiol. 2019 May;44(5):148-172
pubmed: 30545650
BMC Public Health. 2015 Jul 23;15:696
pubmed: 26202429
Cancer. 2009 Feb 1;115(3):608-15
pubmed: 19127544
Aust N Z J Public Health. 2021 Feb;45(1):39-45
pubmed: 33347687
Ethn Dis. 2019 Dec 12;29(Suppl 3):641-650
pubmed: 31889769
Lancet. 2020 Jun 27;395(10242):1955-1957
pubmed: 32539937
JCO Glob Oncol. 2020 Mar;6:83-91
pubmed: 32213083
Trials. 2021 May 10;22(1):337
pubmed: 33971916